These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
714 related articles for article (PubMed ID: 21169662)
21. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery. Cirri M; Bragagni M; Mennini N; Mura P Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833 [TBL] [Abstract][Full Text] [Related]
22. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies. Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458 [TBL] [Abstract][Full Text] [Related]
23. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY; Fang CL; Liu CH; Su YH Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447 [TBL] [Abstract][Full Text] [Related]
24. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
25. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution. Shen J; Deng Y; Jin X; Ping Q; Su Z; Li L Int J Pharm; 2010 Dec; 402(1-2):248-53. PubMed ID: 20934499 [TBL] [Abstract][Full Text] [Related]
26. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique. Severino P; Santana MH; Souto EB Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934 [TBL] [Abstract][Full Text] [Related]
27. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Balguri SP; Adelli GR; Majumdar S Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755 [TBL] [Abstract][Full Text] [Related]
28. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555 [TBL] [Abstract][Full Text] [Related]
29. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Kawadkar J; Pathak A; Kishore R; Chauhan MK Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934 [TBL] [Abstract][Full Text] [Related]
30. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Tiwari R; Pathak K Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809 [TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release. Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903 [TBL] [Abstract][Full Text] [Related]
32. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157 [TBL] [Abstract][Full Text] [Related]
33. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. Liu R; Liu Z; Zhang C; Zhang B J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401 [TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464 [TBL] [Abstract][Full Text] [Related]
37. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study. Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230 [TBL] [Abstract][Full Text] [Related]
38. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system. Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167 [TBL] [Abstract][Full Text] [Related]
39. Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex. Kasongo KW; Shegokar R; Müller RH; Walker RB Drug Dev Ind Pharm; 2011 Apr; 37(4):396-407. PubMed ID: 20923388 [TBL] [Abstract][Full Text] [Related]
40. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil. Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]